
Diabetic Retinopathy
by Duh, Elia J., M.D.-
This Item Qualifies for Free Shipping!*
*Excludes marketplace orders.
Buy New
Rent Textbook
Rent Digital
Used Textbook
We're Sorry
Sold Out
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Table of Contents
Preface | p. v |
Contributors | p. ix |
Clinical Aspects of Diabetic Retinopathy | |
Nonproliferative Diabetic Retinopathy | p. 3 |
Proliferative Diabetic Retinopathy | p. 29 |
The Epidemiology of Diabetic Retinopathy | p. 67 |
Diagnostic Modalities in Diabetic Retinopathy | p. 109 |
Pathophysiology/Basic Research | |
In Vivo Models of Diabetic Retinopathy | p. 137 |
Pathways of Hyperglycemia-induced Damage | |
The Polyol Pathway and Diabetic Retinopathy | p. 159 |
The Role of Advanced Glycation in Diabetic Retinopathy | p. 187 |
The Role of Protein Kinase C in Diabetic Retinopathy | p. 207 |
Oxidative Stress in Diabetic Retinopathy | p. 217 |
Pathophysiological Process in Diabetic Retinopathy | |
Pericyte Loss in the Diabetic Retina | p. 245 |
Capillary Dropout in Diabetic Retinopathy | p. 265 |
Neuroglial Dysfunction in Diabetic Retinopathy | p. 283 |
The Role of Inflammation in the Pathophysiology of Diabetic Retinopathy | p. 303 |
Vascular Permeability in Diabetic Retinopathy | p. 333 |
Retinal Neovascularization and the Role of VEGF | p. 353 |
Beyond VEGF - Other Factors Important in Retinal Neovascularization: Potential Targets in Proliferative Diabetic Retinopathy | p. 375 |
Emerging Treatments and Concepts in Diabetic Retinopathy | |
Anti-VEGF Therapy as an Emerging Treatment for Diabetic Retinopathy | p. 401 |
Clinical Trials in Protein Kinase C-[beta] Inhibition in Diabetic Retinopathy | p. 423 |
The Role of Intravitreal Steroids in the Management of Diabetic Retinopathy | p. 435 |
Antagonism of the Growth Hormone Axis as a Therapeutic Strategy for Diabetic Retinopathy | p. 449 |
Diabetic Retinopathy and Systemic Complications | p. 466 |
Name Index | p. 483 |
Subject Index | p. 489 |
Table of Contents provided by Ingram. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.